Artiva Biotherapeutics, Inc. — Form D
Artiva Biotherapeutics, Inc. of San Diego, CA, a company, filed a Form D exempt-offering notice with the SEC on 2021-04-05. The offering totals $120.0M, of which $120.0M was reported sold. Industry: Biotechnology.
Offering
- Filed: 2021-04-05
- Form: D
- Accession: 0001817241-21-000001
- Industry: Biotechnology
- Exemptions: 06b
- Total offering: $120.0M
- Amount sold: $120.0M
- Investors: 27
- Date of first sale: 2021-02-22
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-394686
Issuer
- Name: Artiva Biotherapeutics, Inc.
- CIK: 0001817241
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2019
- Address: 4747 Executive Drive, Suite 1150, San Diego, CA, 92121
- Phone: 858-267-4467
Officers, directors & promoters (14)
| Name | Role | Location |
|---|
| Fred Aslan | Director | San Diego, CA |
| Brian J Daniels | Director | San Diego, CA |
| Yong-Jun J Huh | Director | San Diego, CA |
| Yu-Kyeong J Hwang | Director | San Diego, CA |
| Bong J Koh | Director | San Diego, CA |
| Laura J Stoppel | Director | San Diego, CA |
| Yvonne J Yamanaka | Director | San Diego, CA |
| Fred Aslan | Executive Officer | San Diego, CA |
| Jennifer J Bush | Executive Officer | San Diego, CA |
| Thomas J Farrell | Executive Officer | San Diego, CA |
| Peter J Flynn | Executive Officer | San Diego, CA |
| Jason J Litten | Executive Officer | San Diego, CA |
| Esther J van den Boom | Executive Officer | San Diego, CA |
| Thomas J Farrell | Director | San Diego, CA |
Other filings by this issuer (1)
More